[1] State Drug Administration.Technical guidelines for clinical evaluation of TCM drug-induced liver injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2018, 34(7):1403-1409. [2] ZHAO LY, ZHAO ZP, CHENG YQ, et al.Research progress of Chinese herbal medicine induced drug-induced liver injury[J]. Chinese Journal of Convalescent Medicine(中国疗养医学), 2019, 28(1) : 48-50. [3] YU LC, MAO YM, CHEN CW.Guidelines for the management of drug-induced liver injury[J]. Journal of Practical Hepatology(实用肝脏病杂志), 2017, 20(2): 257-274. [4] ZHANG L,YANG XH, SUN ZX, et al.Retrospective study on clinical adverse events and risk control measures of Polygonum multiflorum[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2009, 34(13): 1724-1729. [5] MA H, SHI J, SU JR.Pareto diagram analysis of 1140 cases of adverse drug reactions[J]. Chinese Remedies & Clinics(中国药物与临床), 2013, 13(6): 810-811. [6] Ministry of Health. Administrative Measures for Reporting and Monitoring Adverse Drug Reactions(Ministry of Health Decree No. 81)[EB/OL]. (2011-05-04)[2022-07-28]. http:// www.nhc.gov.cn/wjw/bmgz/201105/b442a66fc52b4793a57160002ac2a1a9.shtml. [7] National Administration of Traditional Chinese Medicine. Guidelines of Chinese Patent Medicine[N]. China News of Traditional Chinese Medicine, 2010-07-02 (3). [8] ZHU Y, LI YG, WANG Y, et al.Clinical analysis of 595 cases of liver injury caused by Chinese medicine[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2016, 36(1):44-48. [9] TAKIKAWA H, MURATE Y, HORIIKE N, et al.Drug-induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006[J]. Hepatology research: the official journal of the Japan Society of Hepatology, 2009, 39(5): 427-431. [10] FU XC, SHEN XL, JIANG P, et al.Research progress on liver toxicity of Tripterygium glycosides[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2019, 28(36): 4102-4104. [11] LIU YY.1 case of liver injury caused by Runzao Zhipri capsule[J]. Chinese Hepatology(肝脏), 2020, 25(5): 556-557. [12] YANG ZW, ZHOU YY, TANG Y, et al.Cases analysis of liver injury associated with Qubai Babu tablets[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2019, 9(3): 198-202. [13] CHEUNG WI, TSE ML, NGAN T, et al.Liver injury associated with the use of fructus psoraleae( Bol-gol-zhee or Buguzhi) and its related proprietary-medicine[J]. Clin Toxicol,2009,47(7) : 683-685. [14] YANG YQ, PENG GL.Severe liver injury caused by Xianling Gubao capsule: a case report[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2013, 10(1): 62-62. [15] WANG B, SUN XY, LI JF, et al.Severe hepatic injury caused by Xuesaitong for injection[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2020,10(2): 115-117. [16] LI S, WANG XJ, ZHUANG W, et al.Analysis of 39 cases of adverse reactions/events in Xianling Gubao capsules[J]. China Pharmacist(中国药师), 2019, 22(6): 1068-1071. [18] CHEN Y, HE J, SHANGGUAN XF, et al.Analysis of adverse drug reactions and medication safety in 38 425 children from Hubei province[J]. Herald of Medicine(医药导报), 2020, 39(10): 1362-1365. |